Sigilon is a clinical-stage biotechnology company pioneering a new class of therapeutics and seeking to develop functional cures for patients with chronic diseases.
Company Profile
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Stock Quote
-
Price
-
Change
$0
-
High